High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer-Reference-Cited by-同舟云学术

High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer

Published:2016-07-27 Issue:10 Volume:37 Page:13489-13498
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Chen Xiuli,Qian Dong,Cheng Jingjing,Guan Yong,Zhang Bin,Ding Xiaofeng,Zeng Jing,Chen Xi,Er Puchun,Zhang Furong,Zhao Na,Chen Xiaocen,Zhao Lujun,Yuan Zhiyong,Pang Qingsong,Wang Ping

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5192-x.pdf

Reference41 articles.

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

2. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.

3. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T, Group LC. Lung adjuvant cisplatin evaluation: a pooled analysis by the lace collaborative group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26:3552–9.

4. Feliciano J, Feigenberg S, Mehta M. Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer. Cancer J. 2013;19:222–30.

5. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071–8.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBV promotes its replication by up-regulating RAD51C gene expression;Scientific Reports;2024-01-31

2. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management;Journal of Cancer Research and Clinical Oncology;2023-04-19

3. A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives;AME Medical Journal;2023-03

4. HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism;Journal of Translational Medicine;2023-02-15

5. Testis-expressed gene 11 inhibits cisplatin-induced DNA damage and contributes to chemoresistance in testicular germ cell tumor;Scientific Reports;2022-11-01